Cargando…

The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients

The population undergoing dialysis is aging worldwide, particularly in Japan. The clinical condition of frailty is the most problematic expression in the elderly population. Potential pathophysiological factors of frailty present in patients with CKD and are accentuated in patients with ESRD. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Hidemi, Uchida, Haruhito A., Kakio, Yuki, Okuyama, Yuka, Okuyama, Michihiro, Umebayashi, Ryoko, Wada, Kentaro, Sugiyama, Hitoshi, Sugimoto, Ken, Rakugi, Hiromi, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963342/
https://www.ncbi.nlm.nih.gov/pubmed/29896410
http://dx.doi.org/10.14336/AD.2017.0429
_version_ 1783325033116991488
author Takeuchi, Hidemi
Uchida, Haruhito A.
Kakio, Yuki
Okuyama, Yuka
Okuyama, Michihiro
Umebayashi, Ryoko
Wada, Kentaro
Sugiyama, Hitoshi
Sugimoto, Ken
Rakugi, Hiromi
Wada, Jun
author_facet Takeuchi, Hidemi
Uchida, Haruhito A.
Kakio, Yuki
Okuyama, Yuka
Okuyama, Michihiro
Umebayashi, Ryoko
Wada, Kentaro
Sugiyama, Hitoshi
Sugimoto, Ken
Rakugi, Hiromi
Wada, Jun
author_sort Takeuchi, Hidemi
collection PubMed
description The population undergoing dialysis is aging worldwide, particularly in Japan. The clinical condition of frailty is the most problematic expression in the elderly population. Potential pathophysiological factors of frailty present in patients with CKD and are accentuated in patients with ESRD. The aim of this study was to identify the prevalence and predictors of frailty in Japanese HD patients. This study was a multicenter, cross-sectional and observational investigation conducted at 6 institutions. To evaluate frailty, the modified Fried’s frailty phenotype adjusted for Japanese as the self-reported questionnaire was used. Of the 542 patients visiting each institution, 388 were enrolled in this study. In total, 26.0% of participants were categorized as not-frailty, 52.6% as pre-frailty and 21.4% as frailty. The prevalence of frailty increased steadily with age and was more prevalent in females than in males and the subjects with frailty received polypharmacy. A multivariate logistic regression analysis revealed that the factors independently associated with frailty were the following: female gender (odds ratio [OR] = 3.661, 95% confidence interval [CI] 1.398-9.588), age (OR = 1.065, 95% CI 1.014-1.119), age ≥ 75 years old (OR = 4.892, 95% CI 1.715-13.955), body mass index (BMI) < 18.5 (OR = 0.110, 95% CI 0.0293-0.416), number of medications being taken (OR = 1.351, 95% CI 1.163-1.570), diabetes mellitus (DM) (OR = 2.765, 95% CI 1.081-7.071) and MNA-SF ≤ 11 (OR = 7.405, 95% CI 2.732-20.072). Frailty was associated with the accumulation of risk factors. The prevalence of frailty in Japanese patients with HD was relatively lower than that previously reported in Western developed countries; however, it was extremely high compared to the general population regardless of age. Our findings suggest that frailty might be associated with an increase in the prevalence of adverse health outcomes in patients with HD.
format Online
Article
Text
id pubmed-5963342
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher JKL International LLC
record_format MEDLINE/PubMed
spelling pubmed-59633422018-06-12 The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients Takeuchi, Hidemi Uchida, Haruhito A. Kakio, Yuki Okuyama, Yuka Okuyama, Michihiro Umebayashi, Ryoko Wada, Kentaro Sugiyama, Hitoshi Sugimoto, Ken Rakugi, Hiromi Wada, Jun Aging Dis Orginal Article The population undergoing dialysis is aging worldwide, particularly in Japan. The clinical condition of frailty is the most problematic expression in the elderly population. Potential pathophysiological factors of frailty present in patients with CKD and are accentuated in patients with ESRD. The aim of this study was to identify the prevalence and predictors of frailty in Japanese HD patients. This study was a multicenter, cross-sectional and observational investigation conducted at 6 institutions. To evaluate frailty, the modified Fried’s frailty phenotype adjusted for Japanese as the self-reported questionnaire was used. Of the 542 patients visiting each institution, 388 were enrolled in this study. In total, 26.0% of participants were categorized as not-frailty, 52.6% as pre-frailty and 21.4% as frailty. The prevalence of frailty increased steadily with age and was more prevalent in females than in males and the subjects with frailty received polypharmacy. A multivariate logistic regression analysis revealed that the factors independently associated with frailty were the following: female gender (odds ratio [OR] = 3.661, 95% confidence interval [CI] 1.398-9.588), age (OR = 1.065, 95% CI 1.014-1.119), age ≥ 75 years old (OR = 4.892, 95% CI 1.715-13.955), body mass index (BMI) < 18.5 (OR = 0.110, 95% CI 0.0293-0.416), number of medications being taken (OR = 1.351, 95% CI 1.163-1.570), diabetes mellitus (DM) (OR = 2.765, 95% CI 1.081-7.071) and MNA-SF ≤ 11 (OR = 7.405, 95% CI 2.732-20.072). Frailty was associated with the accumulation of risk factors. The prevalence of frailty in Japanese patients with HD was relatively lower than that previously reported in Western developed countries; however, it was extremely high compared to the general population regardless of age. Our findings suggest that frailty might be associated with an increase in the prevalence of adverse health outcomes in patients with HD. JKL International LLC 2018-04-01 /pmc/articles/PMC5963342/ /pubmed/29896410 http://dx.doi.org/10.14336/AD.2017.0429 Text en Copyright: © 2018 Takeuchi et al. http://creativecommons.org/licenses/by/2.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Orginal Article
Takeuchi, Hidemi
Uchida, Haruhito A.
Kakio, Yuki
Okuyama, Yuka
Okuyama, Michihiro
Umebayashi, Ryoko
Wada, Kentaro
Sugiyama, Hitoshi
Sugimoto, Ken
Rakugi, Hiromi
Wada, Jun
The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
title The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
title_full The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
title_fullStr The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
title_full_unstemmed The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
title_short The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
title_sort prevalence of frailty and its associated factors in japanese hemodialysis patients
topic Orginal Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963342/
https://www.ncbi.nlm.nih.gov/pubmed/29896410
http://dx.doi.org/10.14336/AD.2017.0429
work_keys_str_mv AT takeuchihidemi theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT uchidaharuhitoa theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT kakioyuki theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT okuyamayuka theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT okuyamamichihiro theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT umebayashiryoko theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT wadakentaro theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT sugiyamahitoshi theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT sugimotoken theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT rakugihiromi theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT wadajun theprevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT takeuchihidemi prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT uchidaharuhitoa prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT kakioyuki prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT okuyamayuka prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT okuyamamichihiro prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT umebayashiryoko prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT wadakentaro prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT sugiyamahitoshi prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT sugimotoken prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT rakugihiromi prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients
AT wadajun prevalenceoffrailtyanditsassociatedfactorsinjapanesehemodialysispatients